Document is current
Any future updates will be listed below
-
Authors
Noronha, Vanita
Menon, Nandini
Patil, Vijay M.
Shah, Minit
Joshi, Amit
Shah, Srushti
Nawale, Kavita
Surve, Rohan
Bafna, Gunj
Jogdhankar, Shweta
Shelar, Priyanka
Shetake, Ankush
Singh, Ashish
Salian, Sushmita
Jadhav, Pundlik
Shah, Hetakshi
Mer, Neha
Vohra, Ananya
Majumdar, Swaratika
Banavali, Shripad
Badwe, Rajendra
Prabhash, Kumar https://orcid.org/0000-0001-8858-5004
-
Funding
Funding for this research was provided by:
DAE | TMC | Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre
- License Information
-
More Information
Article History
Received: 17 August 2024
Revised: 11 November 2024
Accepted: 12 November 2024
First Online: 26 November 2024
Competing interests
: VN has received research grants (paid to the institution) from Astra Zeneca, Merck, Novartis, Roche Products (India) Pvt. Ltd., Nanobiotix, and Johnson & Johnson. All research grants have been paid to the institution. KP has received institutional research funding from Pfizer, Roche Products (India) Pvt. Ltd., and Alkem. All research grants have been paid to the institution. None of the other authors have any conflict of interest.
: The study protocol was approved by the Institutional Ethics Committee of Tata Memorial Hospital (Approval number: OIEC/3469/2020/00001) and the study was monitored by the Data Safety and Monitoring Subcommittee. The study was prospectively registered with the Clinical Trials Registry-India, CTRI/2020/11/029275 (). All patients provided written informed consent. We strictly adhered to the ethical guidelines as established by the Declaration of Helsinki, and Good Clinical Practice Guidelines.
